Scott A, Mohr D, Littrell W, Babu R, Kokosinski M, Stinnett V
Genes (Basel). 2024; 15(10).
PMID: 39457378
PMC: 11507229.
DOI: 10.3390/genes15101254.
Petrescu D, Yustein J, Dasgupta A
Front Oncol. 2024; 14:1388484.
PMID: 39091911
PMC: 11291195.
DOI: 10.3389/fonc.2024.1388484.
Yao M, Lei Z, Peng F, Wang D, Li M, Zhong G
BMC Cancer. 2024; 24(1):703.
PMID: 38849717
PMC: 11162025.
DOI: 10.1186/s12885-024-12361-z.
Griffin K, Mizenko R, Arun V, Carney R, Leach J
Adv Biol (Weinh). 2024; 8(6):e2300577.
PMID: 38596830
PMC: 11178448.
DOI: 10.1002/adbi.202300577.
McAloney C, Makkawi R, Budhathoki Y, Cannon M, Franz E, Gross A
Cell Oncol (Dordr). 2023; 47(1):259-282.
PMID: 37676378
PMC: 10899530.
DOI: 10.1007/s13402-023-00867-w.
Role of animal models in biomedical research: a review.
Mukherjee P, Roy S, Ghosh D, Nandi S
Lab Anim Res. 2022; 38(1):18.
PMID: 35778730
PMC: 9247923.
DOI: 10.1186/s42826-022-00128-1.
Two Beats One: Osteosarcoma Therapy with Light-Activated and Chemo-Releasing Keratin Nanoformulation in a Preclinical Mouse Model.
Martella E, Dozza B, Ferroni C, Obeyok C, Guerrini A, Tedesco D
Pharmaceutics. 2022; 14(3).
PMID: 35336051
PMC: 8950553.
DOI: 10.3390/pharmaceutics14030677.
Impact of limb amputation and cisplatin chemotherapy on metastatic progression in mouse models of osteosarcoma.
Ren L, Huang S, Beck J, LeBlanc A
Sci Rep. 2021; 11(1):24435.
PMID: 34952927
PMC: 8709858.
DOI: 10.1038/s41598-021-04018-9.
Thrombospondin-1 induced programmed death-ligand 1-mediated immunosuppression by activating the STAT3 pathway in osteosarcoma.
Liu Z, Wen J, Hu F, Wang J, Hu C, Zhang W
Cancer Sci. 2021; 113(2):432-445.
PMID: 34927311
PMC: 8819289.
DOI: 10.1111/cas.15237.
Endogenous retrovirus envelope as a tumor-associated immunotherapeutic target in murine osteosarcoma.
Wedekind M, Miller K, Chen C, Wang P, Hutzen B, Currier M
iScience. 2021; 24(7):102759.
PMID: 34278266
PMC: 8267546.
DOI: 10.1016/j.isci.2021.102759.
Research models and mesenchymal/epithelial plasticity of osteosarcoma.
Yu X, Yustein J, Xu J
Cell Biosci. 2021; 11(1):94.
PMID: 34022967
PMC: 8141200.
DOI: 10.1186/s13578-021-00600-w.
The CD24 cell subset promotes invasion and metastasis in human osteosarcoma.
Zhou Z, Li Y, Kuang M, Wang X, Jia Q, Cao J
EBioMedicine. 2020; 51:102598.
PMID: 31901872
PMC: 6948162.
DOI: 10.1016/j.ebiom.2019.102598.
Jaw osteosarcoma models in mice: first description.
Bertin H, Guilho R, Brion R, Amiaud J, Battaglia S, Moreau A
J Transl Med. 2019; 17(1):56.
PMID: 30813941
PMC: 6391788.
DOI: 10.1186/s12967-019-1807-5.
Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations.
Loh A, Stewart E, Bradley C, Chen X, Daryani V, Stewart C
Cancer Lett. 2018; 442:262-270.
PMID: 30395907
PMC: 6342199.
DOI: 10.1016/j.canlet.2018.10.033.
Does rarity mean imparity? Biological characteristics of osteosarcoma cells originating from the spine.
Zhou Z, Li Y, Yan X, Wang X, Yang C, Wei H
J Cancer Res Clin Oncol. 2017; 143(10):1959-1969.
PMID: 28551767
DOI: 10.1007/s00432-017-2448-9.
miR-34a is downregulated in human osteosarcoma stem-like cells and promotes invasion, tumorigenic ability and self-renewal capacity.
Zou Y, Huang Y, Yang J, Wu J, Luo C
Mol Med Rep. 2017; 15(4):1631-1637.
PMID: 28260055
PMC: 5364984.
DOI: 10.3892/mmr.2017.6187.
In vivo pharmacological evaluation and efficacy study of methotrexate-encapsulated polymer-coated layered double hydroxide nanoparticles for possible application in the treatment of osteosarcoma.
Ray S, Saha S, Sa B, Chakraborty J
Drug Deliv Transl Res. 2017; 7(2):259-275.
PMID: 28050892
DOI: 10.1007/s13346-016-0351-6.
Cisplatin-resistant osteosarcoma cells possess cancer stem cell properties in a mouse model.
Yang J, Guo W, Wang L, Yu L, Mei H, Fang S
Oncol Lett. 2016; 12(4):2599-2605.
PMID: 27698833
PMC: 5038486.
DOI: 10.3892/ol.2016.4956.
In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.
Leon I, Cadavid-Vargas J, Resasco A, Maschi F, Ayala M, Carbone C
J Biol Inorg Chem. 2016; 21(8):1009-1020.
PMID: 27696106
DOI: 10.1007/s00775-016-1397-0.
Osteosarcoma: mouse models, cell of origin and cancer stem cell.
Guijarro M
Postdoc J. 2016; 2(2):19-30.
PMID: 27617267
PMC: 5014233.
DOI: 10.14304/surya.jpr.v2n2.3.